News
Royal Caribbean Cruises Ltd. (NYSE:RCL) is one of the most profitable consumer stocks to buy now. Royal Caribbean (NYSE:RCL) ...
Chris Senyek, Wolfe Research chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks, ...
6d
Fintel on MSNWolfe Research Downgrades Realty Income (O)
Fintel reports that on July 15, 2025, Wolfe Research downgraded their outlook for Realty Income (NYSE:O) from Outperform to ...
6don MSN
Wolfe Research Affirms Outperform Rating on Johnson & Johnson (JNJ) on Improving Fundamentals
Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research ...
Wolfe Research is urging investors to broaden their exposure in digital assets, arguing that the time has come to rotate more ...
In a report released today, Peter Supino from Wolfe Research reiterated a Buy rating on Netflix, with a price target of $1,390.00. The company’s shares closed yesterday at $1,274.17. Supino covers the ...
Ryder System, Inc. (NYSE:R) is one of the Top 10 Transportation and Industrial Stocks to Buy Now. Wolfe Research upgraded the ...
Detailed price information for Vertiv Holdings Llc. (VRT-N) from The Globe and Mail including charting and trades.
QXO Inc. (NYSE:QXO) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. On June 6, Wolfe Research began coverage of QXO Inc. (NYSE:QXO) with a price target of $44 ...
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 10 biotech stocks screaming a buy. On June 17, Wolfe Research initiated coverage of the stock with an ‘Outperform’ rating and a $49 price target.
Wolfe Research raised the firm’s price target on Workiva (WK) to $120 from $100 and keeps an Outperform rating on the shares. In a research note ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results